SOD1 and Parkinson disease: We propose that this underlies increased SOD1 oxidation and glycation in the Parkinson disease SNc in this study, both of which increase the propensity of the protein to aggregate [55, 61] and may contribute to the accumulation of disSOD1 pathology in this region (Fig. 7).